MLH1 and neoplasm: Immunostaining for the four MMR proteins confirmed loss of MLH1 and PMS2 (Figure 2A), and MSI molecular testing revealed that the tumor was indeed MSI-H, due to the alteration of three mononucleotide markers (BAT25, BAT26, Mono-27) (Figure 2B).